🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Liftoff!

Check out our latest research on phospholamban p.Arg14del cardiomyopathy published in Scientific Reports available via open access nature.com/articles/s4159… Rudolf de Boer @p_van_der_meer Bas Boukens J.Peter van Tintelen UMCG Cardiology Research Institute Research UMCG

New Open Access: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy ift.tt/316Idyo #umcg #openaccess

Check out our new spotlight item on the website about a translational model of PLN cardiomyopathy. #PLN #cardiology #research #scientificreports #nature Scientific Reports Tim Eijgenraam Rudolf de Boer groningencardiology.com/spotlights/pub…

Who is joining our team UMCG. Looking for two new colleagues to join UMCG Cardiology Research Institute werkenbijumcg.nl/-/vacatures/re…

Alle bierdoppen verzamelen! Harrie Kampinga van het UMCG in Groningen financiert er belangrijk onderzoek naar de erfelijke ziekte van Huntington mee dvhn.nl/groningen/Alle…

Excited to see that the final open access version of our review article “Current understanding of fibrosis in genetic cardiomyopathies” is now available online: doi.org/10.1016/j.tcm.… Rudolf de Boer UMCG Cardiology Research Institute Research UMCG

The importance of patient registries and biobanks in genetic cardiomyopathy research. Our Hartstichting HCM CVON Dosis program as an example doi.org/10.1007/s12471… Rudolf de Boer Tim Eijgenraam Magdalena Harakalova Freyja van Lint UMCG Cardiology Research Institute Folkert Asselbergs @

Join us on November 3rd for our Multidimensional Cardiovascular Workshop! This #workshop will feature a live demo of cardiovascular ultrasound and photoacoustic applications using the #Vevo3100 and #LAZRX platform! Register today! visualsonics.com/event/workshop… #seeingmorematters

Daan Westenbrink UMCG UMCG Cardiology Research Institute Tim Eijgenraam

UMCG researchers Niels Grote Beverborg and Peter van der Meer studied a new treatment for #heartfailure. The data of their research shows that this new form of treatment is a promising strategy in treating heart failure. Read more: ow.ly/RlLl50G0MUh #researchimpact #umcgimpact

YIA Basic Science- ✔️ PLN cardiomyopathy is a pathogenic cause of HFrEF Treatment with PLN-ASO, ✔️ reduces PLN protein aggregates and fibrosis ✔️ improves cardiac function and life span, in early and advanced disease #HeartFailure2022 European Society of Cardiology UMCG Cardiology Research Institute Tim Eijgenraam

UMCG Cardiology Research Institute attending #HeartFailure2022 😍